FDA Approves Two Skin Cancer Treatments for GlaxoSmithKline

GlaxoSmithKline

won approval for two drugs to treat advanced skin cancer that are accompanied by diagnostic tests to help target the treatments. The Food and Drug Administration approved Tafinlar and Mekinist for patients with melanoma, the most dangerous form of skin cancer, that has spread or can't be surgically removed, the agency said today in a statement.